Compare JBGS & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBGS | CRON |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 961.2M |
| IPO Year | 2017 | N/A |
| Metric | JBGS | CRON |
|---|---|---|
| Price | $17.82 | $2.62 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 646.0K | ★ 1.1M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.91% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $501,226,000.00 | $132,357,000.00 |
| Revenue This Year | N/A | $19.67 |
| Revenue Next Year | $1.79 | $30.56 |
| P/E Ratio | ★ N/A | $26.24 |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $13.28 | $1.60 |
| 52 Week High | $24.30 | $3.16 |
| Indicator | JBGS | CRON |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 60.82 |
| Support Level | $17.38 | $2.47 |
| Resistance Level | $18.51 | $2.55 |
| Average True Range (ATR) | 0.55 | 0.08 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 58.96 | 95.45 |
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.